Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Current Deferred Tax Assets (2009 - 2010)

Updated

Protagenic Therapeutics, Inc.new's Current Deferred Tax Assets was -$71.00 in fiscal Q4 2010 (quarter ended Dec 31, 2010), compared with -$1,610 a year earlier.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Current Deferred Tax Assets (2009 - 2010) Analysis & Trends

  • In earlier fiscal years, Current Deferred Tax Assets was -$1,610 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -71.00
Dec 31, 2009 -1,610.00
API Access

Protagenic Therapeutics, Inc.new Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=PTIX&period=max&api_key=YOUR_API_KEY